Latest news
Medicare Will Require Breakthrough Devices to Prove Substantial Clinical Improvement for Extra Hospital Payments - Medical DailyMedical Daily · Wed, 05 Aug 2026 10:20:33 GMTLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - Investing News NetworkInvesting News Network · Mon, 03 Aug 2026 18:05:01 GMTMedicare eliminates key pathways used by ‘breakthrough’ devices for extra payments - STATSTAT · Mon, 03 Aug 2026 15:48:43 GMTAccelerating and Modernizing Early and Late-Stage Clinical Development - fda.govfda.gov · Mon, 27 Jul 2026 07:00:00 GMT